Summary

Europe Prosthetic Heart Valve Market
The Europe prosthetic heart valve market was valued at $2.5 billion in 2023 and is projected to reach $7.1 billion by 2033, growing at a CAGR of 11.1% from 2024 to 2033.
A prosthetic heart valve is an artificial device that replaces the damaged native valves of the human heart. Its functioning remains similar to the natural valves, which open and close during every heartbeat to facilitate efficient flow of blood into the whole body. Prosthetic valves are either bioprosthetic that are made from natural tissues extracted from animals or humans. Or they are mechanical, which are created using robust materials such as titanium or carbon. The durability of these devices ensures their functioning for 20-30 years and reduces the possibility of blood clotting near the surface.
The exponentially increasing geriatric population in Europe is expected to increase the number of cases of cardiovascular disorders in the coming years. This is poised to fuel the need for prosthetic heart valves and propel the growth of the market. In addition, rapid adoption of technological advancements in the healthcare industry is a key driver of the Europe prosthetic heart valve market. For instance, the advent of minimally invasive surgical procedures such as transcatheter-based implantation has led to short recovery times and improved clinical outcomes. To enhance the efficacy of the device, the trend of integrating wireless smart sensors into the valves is gaining prominence. These sensors monitor the pressure gradient and blood flow through the heart in real time, enabling early detection of issues post-surgery.

However, concerns pertaining to the risks associated with the implantation of prosthetic heart valves hamper the development of the market. According to Medindia—an Indian health website—mechanical heart valves have a high possibility of thrombotic and thromboembolic complications, resulting in their failure in 10-15% of the implantation cases. Furthermore, around 3-9% of the surgeries exhibit the risk of death of patients. On the contrary, ongoing research studies to develop biomimetic prosthetic valves are expected to reduce the associated risks and present lucrative opportunities for the market expansion. These types of valves are a combination of synthetic and natural materials that possess enhanced durability and reduced risk of mechanical wear. Therefore, the development of ingenious, long-lasting valves is poised to open new avenues for the Europe prosthetic heart valve market.

Segment Review
The Europe prosthetic heart valve market is segmented into product and region. On the basis of product, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve. Country wise, it is analyzed across Germany, France, the UK, Italy, Spain, and Rest of Europe.
Key Findings
On the basis of product, the transcatheter heart valve segment held a high share of the market in 2023.
Competition Analysis
The leading players operating in the Europe prosthetic heart valve market include Bracco, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott Laboratories, Artivion, Inc., Meril Life Sciences Pvt. Ltd., ShockWave Medical, Inc., Novostia SA, and JenaValve Technology, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
● Tissue Heart Valve
○ Stented Tissue Heart Valve
○ Stentless Tissue Heart Valve
● Mechanical Heart Valve
● Transcatheter Heart Valve
By Country
● Germany
● France
● UK
● Italy
● Spain
● Rest of Europe
● Key Market Players
○ Bracco
○ Edwards Lifesciences Corporation
○ Medtronic
○ Boston Scientific Corporation
○ Abbott Laboratories
○ Artivion, Inc
○ Meril Life Sciences Pvt. Ltd.
○ ShockWave Medical, Inc.
○ Novostia SA
○ JenaValve Technology, Inc.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Share Analysis, By Country
4.2.3. Stented Tissue Heart Valve
4.2.4. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Share Analysis, By Country
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Share Analysis, By Country
CHAPTER 5: EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Country
5.2. Europe
5.2.2. Key Market Trends and Opportunities
5.2.2. Market Size and Forecast, By Product
5.2.3. Market Size and Forecast, By Country
5.2.4.Germany
5.2.4.1. Market Size and Forecast, By Product
5.2.5.France
5.2.5.1. Market Size and Forecast, By Product
5.2.6.UK
5.2.6.1. Market Size and Forecast, By Product
5.2.7.Italy
5.2.7.1. Market Size and Forecast, By Product
5.2.8.Spain
5.2.8.1. Market Size and Forecast, By Product
5.2.9.Rest Of Europe
5.2.9.1. Market Size and Forecast, By Product
CHAPTER 6: COMPETITIVE LANDSCAPE
6.1. Introduction
6.2. Top Winning Strategies
6.3. Product Mapping Of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Top Player Positioning,2023
CHAPTER 7: COMPANY PROFILES
7.1. Bracco
7.1.1. Company Overview
7.1.2. Key Executives
7.1.3. Company Snapshot
7.1.4. Operating Business Segments
7.1.5. Product Portfolio
7.1.6. Business Performance
7.1.7. Key Strategic Moves and Developments
7.2. Edwards Lifesciences Corporation
7.2.1. Company Overview
7.2.2. Key Executives
7.2.3. Company Snapshot
7.2.4. Operating Business Segments
7.2.5. Product Portfolio
7.2.6. Business Performance
7.2.7. Key Strategic Moves and Developments
7.3. Medtronic
7.3.1. Company Overview
7.3.2. Key Executives
7.3.3. Company Snapshot
7.3.4. Operating Business Segments
7.3.5. Product Portfolio
7.3.6. Business Performance
7.3.7. Key Strategic Moves and Developments
7.4. Boston Scientific Corporation
7.4.1. Company Overview
7.4.2. Key Executives
7.4.3. Company Snapshot
7.4.4. Operating Business Segments
7.4.5. Product Portfolio
7.4.6. Business Performance
7.4.7. Key Strategic Moves and Developments
7.5. Abbott Laboratories
7.5.1. Company Overview
7.5.2. Key Executives
7.5.3. Company Snapshot
7.5.4. Operating Business Segments
7.5.5. Product Portfolio
7.5.6. Business Performance
7.5.7. Key Strategic Moves and Developments
7.6. Artivion, Inc
7.6.1. Company Overview
7.6.2. Key Executives
7.6.3. Company Snapshot
7.6.4. Operating Business Segments
7.6.5. Product Portfolio
7.6.6. Business Performance
7.6.7. Key Strategic Moves and Developments
7.7. Meril Life Sciences Pvt. Ltd.
7.7.1. Company Overview
7.7.2. Key Executives
7.7.3. Company Snapshot
7.7.4. Operating Business Segments
7.7.5. Product Portfolio
7.7.6. Business Performance
7.7.7. Key Strategic Moves and Developments
7.8. ShockWave Medical, Inc.
7.8.1. Company Overview
7.8.2. Key Executives
7.8.3. Company Snapshot
7.8.4. Operating Business Segments
7.8.5. Product Portfolio
7.8.6. Business Performance
7.8.7. Key Strategic Moves and Developments
7.9. Novostia SA
7.9.1. Company Overview
7.9.2. Key Executives
7.9.3. Company Snapshot
7.9.4. Operating Business Segments
7.9.5. Product Portfolio
7.9.6. Business Performance
7.9.7. Key Strategic Moves and Developments
7.10. JenaValve Technology, Inc.
7.10.1. Company Overview
7.10.2. Key Executives
7.10.3. Company Snapshot
7.10.4. Operating Business Segments
7.10.5. Product Portfolio
7.10.6. Business Performance
7.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. EUROPE PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 3. EUROPE PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 4. EUROPE PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 5. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 6. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 7. GERMANY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 8. FRANCE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 9. UK PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 10. ITALY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 11. SPAIN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 12. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 13. BRACCO: KEY EXECUTIVES
TABLE 14. BRACCO: COMPANY SNAPSHOT
TABLE 15. BRACCO: OPERATING SEGMENTS
TABLE 16. BRACCO: PRODUCT PORTFOLIO
TABLE 17. BRACCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 18. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 19. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 20. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 21. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 22. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 23. MEDTRONIC: KEY EXECUTIVES
TABLE 24. MEDTRONIC: COMPANY SNAPSHOT
TABLE 25. MEDTRONIC: OPERATING SEGMENTS
TABLE 26. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 27. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 28. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 29. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 30. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 31. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 32. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 33. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 34. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 35. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 36. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 37. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 38. ARTIVION, INC: KEY EXECUTIVES
TABLE 39. ARTIVION, INC: COMPANY SNAPSHOT
TABLE 40. ARTIVION, INC: OPERATING SEGMENTS
TABLE 41. ARTIVION, INC: PRODUCT PORTFOLIO
TABLE 42. ARTIVION, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 43. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 44. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 45. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 46. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 47. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 48. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
TABLE 49. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 50. SHOCKWAVE MEDICAL, INC.: OPERATING SEGMENTS
TABLE 51. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 52. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 53. NOVOSTIA SA: KEY EXECUTIVES
TABLE 54. NOVOSTIA SA: COMPANY SNAPSHOT
TABLE 55. NOVOSTIA SA: OPERATING SEGMENTS
TABLE 56. NOVOSTIA SA: PRODUCT PORTFOLIO
TABLE 57. NOVOSTIA SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 59. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 60. JENAVALVE TECHNOLOGY, INC.: OPERATING SEGMENTS
TABLE 61. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 62. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN EUROPE PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: EUROPE PROSTHETIC HEART VALVE MARKET
FIGURE 10. EUROPE PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
FIGURE 11. EUROPE PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. EUROPE PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. EUROPE PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: EUROPE PROSTHETIC HEART VALVE MARKET
FIGURE 20. TOP PLAYER POSITIONING,2023
FIGURE 21. BRACCO: NET SALES, 2021-2023 ($BILLION)
FIGURE 22. BRACCO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. BRACCO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. ARTIVION, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. ARTIVION, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. ARTIVION, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SHOCKWAVE MEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. NOVOSTIA SA: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. NOVOSTIA SA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. NOVOSTIA SA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. JENAVALVE TECHNOLOGY, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2023 (%)